HHS Unveils Sweeping Plan to Combat Lyme Disease and Advance Treatment

I have been a Lyme disease activist for 17yrs and I can say with absolute certainty that the rush to create a vaccine early in the discovery phase led to the deliberate mishandling of the disease. Ask Google’s Gemini AI if a chronic relapsing seronegative disease fits the vaccine model. All this unimaginable pain and suffering for the sake of a GD vaccine! Pfizer’s Lyme vaccine completed Phase 3 clinical trials awaiting regulatory approval and Paul Auwaerter is a Lead Investigator for this latest vaccine.

Email to Auwaerter:

----- Forwarded Message -----
From: CARL TUTTLE <runagain@comcast.net>
To: Paul Auwaerter <pauwaert@jhmi.edu>
Cc: stephanie.haridopolos@hhs.gov <stephanie.haridopolos@hhs.gov>; jayanta.bhattacharya@nih.gov <jayanta.bhattacharya@nih.gov>
Sent: Monday, June 29, 2026 at 08:28:12 AM EDT
Subject: HHS Unveils Sweeping Plan to Combat Lyme Disease and Advance Treatment

WTAS: HHS Unveils Sweeping Plan to Combat Lyme Disease and Advance Treatment
https://www.hhs.gov/press-room/wtas-hhs-unveils-plan-to-combat-lyme-disease.html

 CONCORD, NH — On May 29, 2026, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. announced a series of major initiatives to strengthen the nation’s response to Lyme disease and other tick-borne illnesses.

Johns Hopkins University School of Medicine
Paul G. Auwaerter, MD, MBA
Clinical Director for the Division of Infectious Diseases

Dr. Auwaerter,

It would appear that you and your colleagues have been excluded from RFK Jr’s plans to combat Lyme disease.   

As past president of the Infectious Diseases Society of America propagating their so-called “Lyme treatment guidelines” isn’t this the equivalent of a slap in the face?

Perhaps now we will see progress.

Carl Tuttle
Independent Researcher
Hudson, NH

Opinion:

“Suppressing evidence of antibiotic resistance is not collaboration, it is collusion.” -Carl Tuttle